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Supplementary Table 1 
Associations of sample source, and interval between sample collection and processing with key parameters of standard and microfilter-




 Sample source  Interval between sample collection and processing 
 Voided urine 
n (column %) 
Bladder wash 
n (column %) p  
≤24 hours 
n (column %) 
>24 hours 
n (column %) p 
All samples  54       16 (100)  38 (100)    25 (100)  29 (100)  
Diagnostic call – standard cytology    1.00    0.21 
 Negativea  41  12 (75.0)  29 (76.3)    17 (68.0)  24 (82.8)  
 Positive  13  6 (25.0)  9 (23.7)    8 (32.0)  5 (17.2)  
Diagnostic call – microfilter cytology    0.19    0.72 
 Negative  38  9 (56.3)  29 (76.3)    17 (68.0)  21 (72.4)  
 Positive  16  7 (43.8)  9 (23.7)    8 (32.0)  8 (27.6)  
Background cells – standard cytology    0.72    0.77 
 None  7  2 (12.5)  5 (13.2)    3 (12.0)  4 (13.8)  
 Present, no effect on evaluation  25  8 (50.0)  17 (44.7)    13 (52.0)  12 (41.4)  
 Present, moderately limits evaluation  18  4 (25.0)  14 (36.8)    8 (32.0)  10 (34.5)  
 Present, severely limits evaluation  4  2 (12.5)  2   (5.3)    1   (4.0)  3 (10.3)  
Background cells – microfilter cytology    0.46    0.54 
 None  27  7 (43.8)  20 (52.7)    14 (56.0)  13 (44.8)  
 Present, no effect on evaluation  23  7 (43.8)  16 (42.1)    9 (36.0)  14 (48.3)  
 Present, moderately limits evaluation  3  2 (12.5)  1   (2.6)    1   (4.0)  2   (6.9)  
 Present, severely limits evaluation  1  0   (0.0)  1   (2.6)    1   (4.0)  0   (0.0)  
 
p-value calculated by Pearson’s chi-square test (or Fisher’s exact test when any expected cell count <5). 
  a Includes paucicellular samples. 
 
